1. Advantages of zero tariff Most anticancer drugs in China are imported. The implementation of zero tariff on imported drugs will reduce the burden of domestic patients, especially cancer patients, and then drive a series of reforms such as drug approval, production and sales, benefit many patients, meet the demand of cancer patients for drugs, improve the domestic medical level and improve the medical drug supply system. Therefore, zero tariff benefits the country and the people.
Two: The reason why anticancer drugs are expensive anticancer drugs are expensive. First, the production cost is high, and anticancer drugs are different from ordinary drugs. They do not need to spend a lot of time, energy and talent to explore. The research team of pharmaceutical companies needs to constantly find the most effective ingredients from various substances, and the difficulty can be imagined. In addition, most of these drugs do not exist, and the failure rate is extremely high, so it is possible to invest a lot of money and manpower. In the end, scientific and technological research failed to successfully develop articles, followed by the lack of drugs. As can be seen from the above, the research and development of such drugs was very difficult at that time, so there were few articles, and most anticancer drugs were imported from abroad, so in short, the drug price was very expensive. With import tariffs, how can such a series of processes be inexpensive? Therefore, zero tariff is beneficial to domestic patients with drugs that can be cured and affordable, benefiting the country and the people. Third, the patent protection period of drugs is generally 20 years, but these 20 years are not counted from the beginning of listing, but from early clinical trials. Therefore, after the drug goes on the market, the patent protection period has passed more than half, so in order to make a profit, general pharmaceutical companies will raise the price of drugs and earn back the cost and profit of drug research and development as much as possible. After all, pharmaceutical companies are not charities and need to make money.
The country implements zero tariff on anticancer drugs, and the inclusion of anticancer drugs in medical insurance is conducive to improving China's drug supply system, so that cancer patients can eat and afford drugs.